Xeris Biopharma Holdings Inc — Quarterly Financial Statistics (NASDAQ:XERS) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 8.3 M-1.98 M10.03 M-182 K-1.27 M 6.61 M Cash from investing activities -9.91 M-250 K13 K279 K71 K 113 K Cash from financing activities -83 K398 K3.14 M-942 K9.46 M 12.05 M Free cash flow 8.3 M-1.98 M10.03 M-182 K-1.27 M 6.61 M

News

Xeris Pharmaceuticals faces earnings test as growth accelerates

Why Are Shares Of Xeris Biopharma Falling Friday? - Xeris Biopharma Holdings (NASDAQ:XERS)

BioCryst Pharmaceuticals (BCRX) Q4 Earnings and Revenues Surpass Estimates

Xeris Biopharma director Shannon sells $176k in shares

Outlook Therapeutics, Intelligent Bio Solutions And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Biohaven (NYSE:BHVN), Cango (NYSE:CANG)

Xeris Pharmaceuticals stock rises as rival drug faces FDA setback

NIO, Nike among market cap stock movers on Wednesday

NIO, Xpeng among market cap stock movers on Wednesday

Jefferies reiterates Buy rating on Xeris Pharmaceuticals stock amid competitor setback

Xeris Biopharma Stock: A Balanced Perspective Needed (NASDAQ:XERS) (Rating Downgrade)

Hecht Beth, Xeris Biopharma chief legal officer, sells $116k in XERS

Xeris Biopharma receives patent allowance for hypothyroidism drug